Comparison of 18F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study

Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT

(2017) Lino M. Sawicki et al.   EUROPEAN RADIOLOGY

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT

(2017) Julian Kirchner et al.   PLoS One

Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study

(2016) Katrijn L M Michielsen et al.   BRITISH JOURNAL OF RADIOLOGY

18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients

(2016) C. Spick et al.   JOURNAL OF NUCLEAR MEDICINE

Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review

(2015) H. Sardain et al.   EJSO

Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT

(2015) Johannes Grueneisen et al.   EUROPEAN JOURNAL OF RADIOLOGY

[18F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results

(2014) Karsten Beiderwellen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging for Whole-Body Staging in Patients With Recurrent Gynecological Malignancies of the Pelvis

(2014) Johannes Grueneisen et al.   INVESTIGATIVE RADIOLOGY

Natural history of recurrences in endometrial carcinoma

(2014) BENGT SORBE et al.   Oncology Letters

ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer

(2014) Neeraj Lalwani et al.   Ultrasound Quarterly

ACR Appropriateness Criteria Staging and Follow-up of Ovarian Cancer

(2013) Donald G. Mitchell et al.   Journal of the American College of Radiology

Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea

(2012) Heon Jong Yoo et al.   Journal of Gynecologic Oncology

Management of recurrent cervical cancer: A review of the literature

(2012) M. Peiretti et al.   SURGICAL ONCOLOGY-OXFORD

The role of FDG-PET/CT in gynaecological cancers

(2012) Andrea G Rockall et al.   CANCER IMAGING

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort

(2011) R Y Zang et al.   BRITISH JOURNAL OF CANCER

Detection of Recurrence by 18F-FDG PET in Patients with Endometrial Cancer Showing No Evidence of Disease

(2010) Sang-Young Ryu et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Treatment for Advanced and Recurrent Endometrial Carcinoma: Combined Modalities

(2010) J. A. Rauh-Hain et al.   ONCOLOGIST

Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma

(2009) Erik Mittra et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT

(2008) Kazuhiro Kitajima et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

CA 125, PET alone, PET–CT, CT and MRI in diagnosing recurrent ovarian carcinoma

(2008) Ping Gu et al.   EUROPEAN JOURNAL OF RADIOLOGY